ExLibris header image
SFX Logo
Title: Idarucizumab, a Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Elderly and Renally Impaired Subjects
Source:

Blood [0006-4971] Glund, Stephan yr:2014


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Glund, S. "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran." Thrombosis and haemostasis 113.5 (2015): 943-51. Link to SFX for this item
2. Pollack, Charles V V. "Idarucizumab for Dabigatran Reversal." The New England journal of medicine 373.6 (2015): 511-520. Link to SFX for this item
3. "Real-world experience with reversal of dabigatran by idarucizumab." Thrombosis research. 197: 179-184. Link to SFX for this item
4. Pollack, C. "INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS." Emergency medicine journal 32.12 (2015): 979-980. Link to SFX for this item
5. Glund, S. "Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial." Lancet (London, England) 386.9994 (2015): 680-90. Link to SFX for this item
6. Pollack, C V V. "Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran." Thrombosis and haemostasis 114.1 (2015): 198-205. Link to SFX for this item
7. Burness, Celeste B. "Idarucizumab: First Global Approval." Drugs 75.18 (2015): 2155-61. Link to SFX for this item
8. Parasrampuria, Dolly A. "Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis." Thrombosis and haemostasis 113.4 (2015): 719-27. Link to SFX for this item
9. "Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature." Frontiers in neurology. 12: 666086-. Link to SFX for this item
10. Bakhru, S. "PER977: A synthetic small molecule which reverses over-dosage and bleeding by the new oral anticoagulants." Circulation 1).22 Supplement (2013). Link to SFX for this item
11. Vanden Daelen, S. "Monitoring and reversal strategies for new oral anticoagulants." Expert review of cardiovascular therapy 13.1 (2014): 1-9. Link to SFX for this item
12. Grottke, O. "In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran." Critical care 18.1 (2014). Link to Full Text for this item Link to SFX for this item
13. Wilson, Jo-Anne S. "An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis." The Journal of clinical pharmacology 54.8 (2014): 901-9. Link to Full Text for this item Link to SFX for this item
14. Man-Son-Hing, M. "Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation: Physicians' Fears Often Unfounded." Archives of internal medicine 163.13 (2003): 1580-1586. Link to SFX for this item
15. Man-Son-Hing, M. "Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls." Archives of internal medicine 159.7 (1999): 677-685. Link to SFX for this item
16. Na, S. "Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran." Annals of neurology 78.1 (2015): 137-141. Link to Full Text for this item Link to SFX for this item
17. Lawitz, Eric J. "A Phase 1, Randomized, Placebo-Controlled, Three-Day, Dose-Ranging Study of GS-5885, an NS5A Inhibitor, in Patients with Genotype 1 Hepatitis C." Journal of hepatology 57.1 (2012): 24-31. Link to SFX for this item
18. Lee, Ju-Hun H. "Symptomatic Hemorrhagic Transformation and Its Predictors in Acute Ischemic Stroke with Atrial Fibrillation." European neurology 64.4 (2010): 193-200. Link to SFX for this item
19. Connolly, Stuart J. "Dabigatran versus Warfarin in Patients with Atrial Fibrillation." New England Journal of Medicine, The 361.12 (2009): 1139-51. Link to SFX for this item
20. Kreuzer, B. "Idarucizumab for Dabigatran Reversal - Full Cohort Analysis." The New England Journal of Medicine 377.5 (2017): 431-441. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.